Journal
NATURE COMMUNICATIONS
Volume 6, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms7200
Keywords
-
Categories
Funding
- AACR [08-20-25-STOR]
- NIH [CA135102, GM86435, CA140182]
- Mayo Clinic SPORE for Pancreatic Cancer [P50CA102701]
- Norwegian Research Council [197261, CA122086, CA142580, CA136754, CA140290, CA081436]
- Pancreatic Cancer Action Network (PanCAN)
- Boshell Foundation
Ask authors/readers for more resources
The transdifferentiation of pancreatic acinar cells to a ductal phenotype (acinar-to-ductal metaplasia, ADM) occurs after injury or inflammation of the pancreas and is a reversible process. However, in the presence of activating Kras mutations or persistent epidermal growth factor receptor (EGF-R) signalling, cells that underwent ADM can progress to pancreatic intraepithelial neoplasia (PanIN) and eventually pancreatic cancer. In transgenic animal models, ADM and PanINs are initiated by high-affinity ligands for EGF-R or activating Kras mutations, but the underlying signalling mechanisms are not well understood. Here, using a conditional knockout approach, we show that protein kinase D1 (PKD1) is sufficient to drive the reprogramming process to a ductal phenotype and progression to PanINs. Moreover, using 3D explant culture of primary pancreatic acinar cells, we show that PKD1 acts downstream of TGF alpha and Kras, to mediate formation of ductal structures through activation of the Notch pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available